Kewal Asosingh
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Immunology and Allergy top 2%
- Cell Adhesion Molecules Research
Papers in
- Hematology 41
- Multiple Myeloma Research and Treatments 36
-
- Cell Adhesion Molecules Research 11
- Co-authors
- Serpil C. ErzurumKarin VanderkerkenIvan Van RietBen Van CampSuzy ComhairWeiling XuHendrik De RaevePeter I. Croucher
- Journals
- Blood (10 papers)Cytometry Part A (9 papers)The Journal of Immunology (6 papers)Pulmonary Circulation (6 papers)JCI Insight (4 papers)
- Partner nations
- United StatesBelgiumUnited Kingdom
In The Last Decade
Kewal Asosingh
115 papers receiving 4.3k citations
Peers
Comparison fields: 5 of 121
- Hematology 1.1k
- Immunology and Allergy 288
- Pulmonary and Respiratory Medicine 1.4k
- Oncology 1.1k
- Cancer Research 578
Countries citing papers authored by Kewal Asosingh
This map shows the geographic impact of Kewal Asosingh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kewal Asosingh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kewal Asosingh more than expected).
Fields of papers citing papers by Kewal Asosingh
This network shows the impact of papers produced by Kewal Asosingh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kewal Asosingh. The network helps show where Kewal Asosingh may publish in the future.
Co-authors
The 25 scholars most cited alongside Kewal Asosingh, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2023 | 4 | |
| 3 | 2023 | 6 | |
| 4 | 2020 | 49 | |
| 5 | 2020 | 56 | |
| 6 | 2014 | 30 | |
| 7 | 2013 | 79 | |
| 8 | 2012 | 80 | |
| 9 | 2011 | 107 | |
| 10 | 2011 | 50 | |
| 11 | 2010 | 112 | |
| 12 | 2009 | 80 | |
| 13 | 2008 | 130 | |
| 14 | Of mice and men, disease models of multiple myeloma. | 2004 | 1 |
| 15 | Multifunctional role of matrix metalloproteinases in multiple myeloma: study in the 5T2mm mouse model. | 2004 | 1 |
| 16 | Osteoprotegerin inhibits the development of osteolytic bone disease in multiple myeloma | 2001 | 1 |
| 17 | 2001 | 34 | |
| 18 | Osteoprotegerin (OPG) inhibits the development of osteolytic bone disease in the 5T2MM model of multiple myeloma. | 2000 | 1 |
| 19 | Bone marrow microenvironmental-induced upregulation of MMP-9 activity in murine multiple myeloma cells | 2000 | 2 |
| 20 | 2000 | 25 |
About Kewal Asosingh
Kewal Asosingh is a scholar working on Hematology, Immunology and Allergy, Pulmonary and Respiratory Medicine, Physiology and Oncology, having authored 118 papers that have together received 4.4k indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (36 papers), Pulmonary Hypertension Research and Treatments (25 papers), Asthma and respiratory diseases (20 papers), Angiogenesis and VEGF in Cancer (13 papers), Neonatal Respiratory Health Research (12 papers), Glycosylation and Glycoproteins Research (11 papers), Cell Adhesion Molecules Research (11 papers) and Nitric Oxide and Endothelin Effects (9 papers). The work is most often cited by research in Hematology (1.1k citations), Immunology and Allergy (288 citations), Pulmonary and Respiratory Medicine (1.4k citations), Oncology (1.1k citations) and Cancer Research (578 citations). Kewal Asosingh has collaborated with scholars based in United States, Belgium and United Kingdom. Frequent co-authors include Serpil C. Erzurum, Karin Vanderkerken, Ivan Van Riet, Ben Van Camp, Suzy Comhair, Weiling Xu, Hendrik De Raeve, Peter I. Croucher, Amit Vasanji and Bela Anand‐Apte. Their work appears in journals such as Blood, Cytometry Part A, The Journal of Immunology, Pulmonary Circulation and JCI Insight.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.